Analyst Viewpoint
Rise in adoption of multimodal imaging is a prominent factor boosting the global biological imaging reagents industry size. Multimodal imaging lowers the detection threshold of an independent technique with the higher detection threshold of the other independent technique to provide better scanning outcome.
Extensive research in usage of quantum physics to enable better detection is one of the key biological imaging reagents market trends.
Companies operating in the global biological imaging reagents market are pairing radionuclides for diagnostic and therapeutic applications to add to the existing methods of radiolabeling and separation.
They are also supplying a suite of cell function kits that help visualize key cellular events including apoptosis, viability, mitochondrial membrane potential, and indicators for calcium, hypoxia, or reactive oxygen species (ROS).
Biological imaging reagents help detect biological processes at molecular level and enable medical physicians/practitioners to obtain diagnostic information to detect and treat diseases, especially in neurology, cardiology, and oncology fields.
Types of biological imaging reagents include fluorescent proteins, fluorescent probes and dyes, nanoparticles, ultrasound and x-ray contrast reagents, MRI, and imaging radiopharmaceuticals.
Advantages of biological imaging reagents include higher sensitivity, multicolor capability, unlimited tissue penetration, and high spatial resolution.
However, high cost of these cell staining and labeling reagents is restraining the biological imaging reagents market growth to a certain extent. Dearth of skilled healthcare professionals is another factor hampering market progress.
| Attribute | Detail |
|---|---|
| Market Drivers |
|
Multimodal imaging, also known as multiplexed imaging, is increasingly being used in identification and treatment of several chronic diseases such as cancers, cardiovascular disorders, ophthalmic disorders, and neurological diseases.
Multimodal imaging techniques such as PET/MRI, PET/CT, and SPECT/CT enable better detection of anatomic, pathophysiological, and molecular changes in single scan that involves administration of radiolabeled peptide probes.
Currently, multimodality studies use hybrid magnetic-fluorescent QD nanoparticles to detect tumors through fluorescent imaging and MRI, thereby allowing for an increase in anatomic information through enhanced resolution.
Growth in prevalence of Chronic Obstructive Pulmonary Disorders (COPDs) is a major factor that is driving the adoption of multimodal imaging techniques worldwide. As per the WHO, COPD is one of leading causes of morbidity and mortality across the globe.
As per GE Healthcare, more than 95 million MRI scans are performed every year at the global level. Biological imaging reagents improve upon visibility of structures that MRI picks up.
Research states that fluorescence-based assays, in conjunction with microscopy, render mechanistic details that their counterparts do not. For instance, the size of glucosome and cytoplasmic enzyme assemblies for metabolism of glucose are modulated in various cell cycle stages for regulating glucose flux between building-block biosynthesis and glycolysis.
Better entailing of these intricacies is driving the fluorescent biological imaging agents market. Healthcare personnel are moving toward bioluminescent imaging probes from the conventional methods in light of benefits such as better luminosity.
Thus, rise in demand for diagnostic imaging devices such as x-ray devices and MRI along with implementation of PACS (Picture Archiving and Communication Systems) is bolstering the biological imaging reagents market.
| Attribute | Detail |
|---|---|
| Leading Region | North America |
As per the latest biological imaging reagents market analysis, North America accounted for the largest share of the global landscape in 2022. The region is expected to maintain its leading position during the forecast period.
High biological imaging reagents market share of North America can be ascribed to the increase in adoption of advanced technologies, such as Artificial Intelligence (AI), in molecular imaging and rise in awareness regarding detection/diagnosis at an early stage in the region.
Europe also recorded significant market expansion in 2022. This can be ascribed to the high number of tests being performed and availability of strong healthcare infrastructure in the region.
Biological imaging reagents market forecast in Asia Pacific and Latin America appears positive owing to the growth in healthcare infrastructure and rise in emphasis on R&D activities in imaging techniques in the region.
Companies operating in the global biological imaging reagents landscape are providing new clinical data for contrast agents in order to introduce reagents with better imaging capacities.
For instance, Thermo Fisher Inc.’s ReadyProbes reagents are ready-to-use imaging solutions that allow staining of cells with no dilutions, calculations, and pipetting.
Leading market players are engaged in new product launches and extensive R&D activities in biological imaging reagents to expand their global reach. For instance, Bayer AG has entered into a partnership with radiology AI providers such as Imagine Software, Qure.ai, Brainomix Limited, and Perspectum Limited to expand its offerings on the Calantic medical imaging platform.
Bayer AG, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Guerbet, Lantheus Holdings, Inc., Bracco S.p.A., GE Healthcare, Becton, Dickinson and Company (BD), Siemens Healthineers, and Luminex Corporation are the key players that have been profiled in the biological imaging reagents market report based on parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.
| Attribute | Detail |
|---|---|
| Market Size in 2022 | US$ 16.8 Bn |
| Market Forecast (Value) in 2031 | US$ 26.9 Bn |
| Growth Rate (CAGR) | 5.4% |
| Forecast Period | 2023-2031 |
| Historical Data Available for | 2017-2021 |
| Quantitative Units | US$ Bn for Value |
| Market Analysis | It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
| Competition Landscape |
|
| Format | Electronic (PDF) + Excel |
| Market Segmentation |
|
| Regions Covered |
|
| Countries Covered |
|
| Companies Profiled |
|
| Customization Scope | Available Upon Request |
| Pricing | Available Upon Request |
It was valued at US$ 16.8 Bn in 2022
It is projected to grow at a CAGR of 5.4% from 2023 to 2031
Growth in adoption of multimodal imaging and rise in demand for diagnostic imaging devices
The diagnostic laboratories segment accounted for the largest share in 2022
North America was the dominant region in 2022
Bayer AG, Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Guerbet, Lantheus Holdings, Inc., Bracco S.p.A., GE Healthcare, Becton, Dickinson and Company (BD), Siemens Healthineers, and Luminex Corporation
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Biological Imaging Reagents Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Biological Imaging Reagents Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Biological Imaging Reagents Market Analysis and Forecast, by Class
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Class, 2017–2031
6.3.1. Contrast Agents
6.3.2. Optical Reagents
6.3.3. Nuclear Agents
6.4. Market Attractiveness, by Class
7. Global Biological Imaging Reagents Market Analysis and Forecast, by Modality
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Modality, 2017–2031
7.3.1. MRI
7.3.2. Ultrasound
7.3.3. X-Ray & CT
7.3.4. Nuclear
7.3.4.1. PET
7.3.4.2. SPECT
7.3.5. Optical Imaging
7.3.6. Others
7.3.7. 7.4 Market Attractiveness, by Modality
8. Global Biological Imaging Reagents Market Analysis and Forecast, By Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, By Application, 2017–2031
8.3.1. In Vitro
8.3.1.1. Proteomics
8.3.1.2. Genomics
8.3.1.3. Cell Biology
8.3.2. In Vivo
8.4. Market Attractiveness, By Application
9. Global Biological Imaging Reagents Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Diagnostic Laboratories
9.3.2. Life Science Companies
9.3.3. Imaging Centers
9.3.4. Academic & Research Institutes
9.3.5. Others
9.4. Market Attractiveness, by End-user
10. Global Biological Imaging Reagents Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2017–2031
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Biological Imaging Reagents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Class, 2017–2031
11.2.1. Contrast Agents
11.2.2. Optical Reagents
11.2.3. Nuclear Agents
11.3. Market Attractiveness, by Class
11.4. Market Value Forecast, by Modality, 2017–2031
11.4.1. MRI
11.4.2. Ultrasound
11.4.3. X-Ray & CT
11.4.4. Nuclear
11.4.4.1. PET
11.4.4.2. SPECT
11.4.5. Optical Imaging
11.4.6. Others
11.5. Market Attractiveness, by Modality
11.6. Market Value Forecast, By Application, 2017–2031
11.6.1. In Vitro
11.6.1.1. Proteomics
11.6.1.2. Genomics
11.6.1.3. Cell Biology
11.6.2. In Vivo
11.7. Market Attractiveness, By Application
11.8. Market Value Forecast, by End-user, 2017–2031
11.8.1. Diagnostic Laboratories
11.8.2. Life Science Companies
11.8.3. Imaging Centers
11.8.4. Academic & Research Institutes
11.8.5. Others
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country/Sub-region, 2017–2031
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Class
11.11.2. By Modality
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Biological Imaging Reagents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Class, 2017–2031
12.2.1. Contrast Agents
12.2.2. Optical Reagents
12.2.3. Nuclear Agents
12.3. Market Attractiveness, by Class
12.4. Market Value Forecast, by Modality, 2017–2031
12.4.1. MRI
12.4.2. Ultrasound
12.4.3. X-Ray & CT
12.4.4. Nuclear
12.4.4.1. PET
12.4.4.2. SPECT
12.4.5. Optical Imaging
12.4.6. Others
12.5. Market Attractiveness, by Modality
12.6. Market Value Forecast, By Application, 2017–2031
12.6.1. In Vitro
12.6.1.1. Proteomics
12.6.1.2. Genomics
12.6.1.3. Cell Biology
12.6.2. In Vivo
12.7. Market Attractiveness, By Application
12.8. Market Value Forecast, by End-user, 2017–2031
12.8.1. Diagnostic Laboratories
12.8.2. Life Science Companies
12.8.3. Imaging Centers
12.8.4. Academic & Research Institutes
12.8.5. Others
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2017–2031
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Class
12.11.2. By Modality
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Biological Imaging Reagents Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Class, 2017–2031
13.2.1. Contrast Agents
13.2.2. Optical Reagents
13.2.3. Nuclear Agents
13.3. Market Attractiveness, by Class
13.4. Market Value Forecast, by Modality, 2017–2031
13.4.1. MRI
13.4.2. Ultrasound
13.4.3. X-Ray & CT
13.4.4. Nuclear
13.4.4.1. PET
13.4.4.2. SPECT
13.4.5. Optical Imaging
13.4.6. Others
13.5. Market Attractiveness, by Modality
13.6. Market Value Forecast, By Application, 2017–2031
13.6.1. In Vitro
13.6.1.1. Proteomics
13.6.1.2. Genomics
13.6.1.3. Cell Biology
13.6.2. In Vivo
13.7. Market Attractiveness, By Application
13.8. Market Value Forecast, by End-user, 2017–2031
13.8.1. Diagnostic Laboratories
13.8.2. Life Science Companies
13.8.3. Imaging Centers
13.8.4. Academic & Research Institutes
13.8.5. Others
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2017–2031
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Class
13.11.2. By Modality
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Biological Imaging Reagents Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Class, 2017–2031
14.2.1. Contrast Agents
14.2.2. Optical Reagents
14.2.3. Nuclear Agents
14.3. Market Attractiveness, by Class
14.4. Market Value Forecast, by Modality, 2017–2031
14.4.1. MRI
14.4.2. Ultrasound
14.4.3. X-Ray & CT
14.4.4. Nuclear
14.4.4.1. PET
14.4.4.2. SPECT
14.4.5. Optical Imaging
14.4.6. Others
14.5. Market Attractiveness, by Modality
14.6. Market Value Forecast, By Application, 2017–2031
14.6.1. In Vitro
14.6.1.1. Proteomics
14.6.1.2. Genomics
14.6.1.3. Cell Biology
14.6.2. In Vivo
14.7. Market Attractiveness, By Application
14.8. Market Value Forecast, by End-user, 2017–2031
14.8.1. Diagnostic Laboratories
14.8.2. Life Science Companies
14.8.3. Imaging Centers
14.8.4. Academic & Research Institutes
14.8.5. Others
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2017–2031
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Class
14.11.2. By Modality
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Biological Imaging Reagents Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Class, 2017–2031
15.2.1. Contrast Agents
15.2.2. Optical Reagents
15.2.3. Nuclear Agents
15.3. Market Attractiveness, by Class
15.4. Market Value Forecast, by Modality, 2017–2031
15.4.1. MRI
15.4.2. Ultrasound
15.4.3. X-Ray & CT
15.4.4. Nuclear
15.4.4.1. PET
15.4.4.2. SPECT
15.4.5. Optical Imaging
15.4.6. Others
15.5. Market Attractiveness, by Modality
15.6. Market Value Forecast, By Application, 2017–2031
15.6.1. In Vitro
15.6.1.1. Proteomics
15.6.1.2. Genomics
15.6.1.3. Cell Biology
15.6.2. In Vivo
15.7. Market Attractiveness, By Application
15.8. Market Value Forecast, by End-user, 2017–2031
15.8.1. Diagnostic Laboratories
15.8.2. Life Science Companies
15.8.3. Imaging Centers
15.8.4. Academic & Research Institutes
15.8.5. Others
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2017–2031
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Class
15.11.2. By Modality
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Bayer AG
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Thermo Fisher Scientific, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. PerkinElmer, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Guerbet
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Lantheus Holdings, Inc.
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Bracco S.p.A.
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. GE Healthcare
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. Becton, Dickinson and Company (BD)
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Siemens Healthineers
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.9.2. Product Portfolio
16.3.9.3. Financial Overview
16.3.9.4. SWOT Analysis
16.3.9.5. Strategic Overview
16.3.10. Luminex Corporation
16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.10.2. Product Portfolio
16.3.10.3. Financial Overview
16.3.10.4. SWOT Analysis
16.3.10.5. Strategic Overview
List of Tables
Table 01: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031
Table 02: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 03: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, By Application, 2017–2031
Table 04: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 05: Global Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031
Table 08: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 09: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, By Application, 2017–2031
Table 10: North America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031
Table 13: Europe Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 14: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 15: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031
Table 16: Asia Pacific Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 17: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 18: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031
Table 19: Latin America Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031
Table 20: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 21: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Class, 2017–2031
Table 22: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast, by Modality, 2017–2031
List of Figures
Figure 01: Global Biological Imaging Reagents Market Size (US$ Mn) and Distribution (%), by Region, 2022–2031
Figure 02: Global Biological Imaging Reagents Market Revenue (US$ Mn), by Class, 2022
Figure 03: Global Biological Imaging Reagents Market Value Share, by Class, 2022
Figure 04: Global Biological Imaging Reagents Market Revenue (US$ Mn), by Modality, 2022
Figure 05: Global Biological Imaging Reagents Market Value Share, by Modality, 2022
Figure 06: Global Biological Imaging Reagents Market Revenue (US$ Mn), By Application, 2022
Figure 07: Global Biological Imaging Reagents Market Value Share, By Application, 2022
Figure 08: Global Biological Imaging Reagents Market Value (US$ Mn) Forecast, 2017–2031
Figure 09: Global Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031
Figure 10: Global Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031
Figure 11: Global Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031
Figure 12: Global Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031
Figure 13: Global Biological Imaging Reagents Market Value Share Analysis, By Application, 2022–2031
Figure 14: Global Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023–2031
Figure 15: Global Biological Imaging Reagents Market Attractiveness Analysis, by Region, 2023–2031
Figure 16: North America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 17: North America Biological Imaging Reagents Market Attractiveness Analysis, by Country, 2023–2031
Figure 18: North America Biological Imaging Reagents Market Value Share Analysis, by Country, 2022–2031
Figure 19: North America Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031
Figure 20: North America Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031
Figure 21: North America Biological Imaging Reagents Market Value Share Analysis, By Application, 2022–2031
Figure 22: North America Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031
Figure 23: Europe Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 24: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 25: Europe Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 26: Europe Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031
Figure 27: Europe Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031
Figure 28: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031
Figure 29: Europe Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031
Figure 30: Europe Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023–2031
Figure 31: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 32: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 33: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031
Figure 34: Asia Pacific Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031
Figure 35: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031
Figure 36: Asia Pacific Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031
Figure 37: Latin America Biological Imaging Reagents Market Value (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 38: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 39: Latin America Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 40: Latin America Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031
Figure 41: Latin America Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031
Figure 42: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031
Figure 43: Latin America Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031
Figure 44: Middle East & Africa Biological Imaging Reagents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2031
Figure 45: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Country/Sub-region, 2023–2031
Figure 46: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Country/Sub-region, 2022–2031
Figure 47: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Class, 2022–2031
Figure 48: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by Modality, 2022–2031
Figure 49: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, By Application, 2022–2031
Figure 50: Middle East & Africa Biological Imaging Reagents Market Value Share Analysis, by End-user, 2022–2031
Figure 51: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Class, 2023–2031
Figure 52: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by Modality, 2023–2031
Figure 53: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, By Application, 2023–2031
Figure 54: Middle East & Africa Biological Imaging Reagents Market Attractiveness Analysis, by End-user, 2023–2031
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Biological Imaging Reagents Market
